Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 3

Sponsor Class

NIH 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Lymphoid 2

Conditions

Sarcoma 39Dendritic Cell Sarcoma, Interdigitating 30Lymphoma 22Burkitt Lymphoma 22Lymphoma, Large B-Cell, Diffuse 20Osteosarcoma 17Neuroectodermal Tumors, Primitive, Peripheral 17Lymphoma, Non-Hodgkin 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia 15Lymphoma, Large-Cell, Immunoblastic 14Lymphoma, Mantle-Cell 12Lymphoma, Follicular 12Leukemia, Myeloid, Acute 12Leukemia, Lymphocytic, Chronic, B-Cell 12Rhabdomyosarcoma 11Lymphoma, B-Cell, Marginal Zone 11Sarcoma, Ewing 10Recurrence 10Neuroblastoma 10Blast Crisis 10Leukemia, Myeloid, Accelerated Phase 9Central Nervous System Neoplasms 9Neoplasms, Plasma Cell 8Myelodysplastic Syndromes 8Multiple Myeloma 8Leukemia, Myeloid, Chronic-Phase 8Hodgkin Disease 8Brain Neoplasms 8Myeloproliferative Disorders 7

Interventions

Zidovudine 10Doxorubicin 10Vincristine 7Bleomycin 7Liposomes 5Interferon alpha-2 5tecogalan 4Etoposide 3sargramostim 2pomalidomide 2liposomal doxorubicin 2interferon alfa-n1 2Valganciclovir 2Ritonavir 2Paclitaxel 2Nivolumab 2Mitoxantrone 2Didanosine 2vesnarinone 1tocilizumab 1tin etiopurpurin 1abemaciclib 1Zalcitabine 1Tumor Necrosis Factor-alpha 1Sorafenib 1Semaxinib 1Ro 24-7429 1O-(Chloroacetylcarbamoyl)fumagillol 1Nevirapine 1Muromonab-CD3 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Etoposide × Sarcoma × Clear all
NCT00000660 2021-11-03

Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
24 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00000807 2021-10-28

Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
41 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00002003 2005-06-24

Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
LymphoidSarcoma

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, HIV Infections, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡